IOVANCE BIOTHERAPEUTICS, INC. - COM (IOVA)

Historical Portfolio Holders from Q2 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
234M
Holdings value Q3 2024
$2.2B
Value change Q3 2024
+$19.5M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
278
Number of buys Q3 2024
139
Number of sells Q3 2024
-123
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 234M $2.2B +$19.5M $9.39 282
2024 Q2 232M $1.86B +$106M $8.02 290
2024 Q1 216M $3.2B +$204M $14.82 270
2023 Q4 207M $1.68B -$23.4M $8.13 235
2023 Q3 212M $965M -$1.2M $4.55 225
2023 Q2 204M $1.44B -$789K $7.04 215
2023 Q1 205M $1.25B +$199M $6.11 223
2022 Q4 173M $1.11B +$100M $6.39 211
2022 Q3 154M $1.48B -$54.9M $9.58 229
2022 Q2 156M $1.73B +$13.1M $11.04 227
2022 Q1 156M $2.59B -$16.4M $16.65 230
2021 Q4 156M $2.96B -$77.1M $19.09 236
2021 Q3 158M $3.88B -$126M $24.66 239
2021 Q2 162M $4.21B +$75.7M $26.02 229
2021 Q1 156M $4.95B +$228M $31.66 241
2020 Q4 149M $6.9B +$436M $46.40 270
2020 Q3 140M $4.61B -$20.1M $32.92 244
2020 Q2 141M $3.88B +$502M $27.45 257
2020 Q1 123M $3.67B -$30.1M $29.94 213
2019 Q4 124M $3.44B +$2.49M $27.68 197
2019 Q3 123M $2.25B +$952K $18.20 167
2019 Q2 122M $3B +$230M $24.52 164
2019 Q1 117M $1.11B -$11M $9.51 148
2018 Q4 119M $1.05B +$237M $8.85 135
2018 Q3 90.4M $1.02B +$78.6M $11.25 130
2018 Q2 83.2M $1.07B +$54.6M $12.80 125
2018 Q1 77.7M $1.31B +$341M $16.90 120
2017 Q4 57.6M $461M +$14.6M $8.00 86
2017 Q3 55.3M $428M +$58.6M $7.75 86
2017 Q2 47.6M $349M +$349M $7.35 83